Diabetes & CV Disease
Sort by:
Practical Ways to Achieve Targets in Diabetes Care
Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target
FEATURING
Steven Nissen
- 4,147 views
- November 8, 2021
- 30
Keck School of Medicine of USC
Effects of Low Calorie and Alternative Sweeteners Across the Lifespan: Magic Bullet or Fool's Gold
FEATURING
Michael Goran
- 4,206 views
- November 30, 2023
- 27
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finally Have Clothes?
FEATURING
Sean Pinney
- 3,011 views
- November 8, 2023
- 26
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What Changed?
FEATURING
Michael Miedema
- 3,371 views
- January 25, 2022
- 24
The Texas Heart Institute
Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
FEATURING
George Bakris
- 2,248 views
- September 7, 2023
- 25
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
- 3,363 views
- August 20, 2018
- 24
National Lipid Association
Colchicine: Now and What’s Next?
FEATURING
Christie Ballantyne
- 4,891 views
- October 11, 2023
- 24
Houston Methodist DeBakey Heart and Vascular Center
Are All Carbs and Fats Created Equally, and What Influence Do Different Carbs Have on Metabolism?
FEATURING
Arthur Agatston
- 4,242 views
- November 26, 2020
- 24
National Lipid Association
The Ketogenic Diet - Where Does the Evidence Stand for ASCVD risk?
FEATURING
Carol Kirkpatrick
- 3,854 views
- March 25, 2019
- 19
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
- 4,129 views
- September 27, 2023
- 23
Practical Ways to Achieve Targets in Diabetes Care
ATDC 2022 Pioglitazone: Summary of Current Knowledge
FEATURING
Steven Nissen
- 2,324 views
- August 23, 2022
- 22
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,780 views
- May 15, 2020
- 22
UT Health San Antonio School of Medicine
Effective Treatment of T2DM Requires Combination Therapy
FEATURING
Ralph DeFronzo
- 2,505 views
- August 30, 2023
- 20
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
- 2,918 views
- August 21, 2018
- 22
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
FEATURING
Barry Greenberg
- 2,010 views
- February 5, 2021
- 22
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,383 views
- August 29, 2023
- 19
Stanford Medicine
Animal vs. Vegetable: Does Food Type Matter?
FEATURING
Christopher Gardner
- 2,247 views
- September 13, 2023
- 20
Stanford Medicine
What's the Ideal Therapy for Obesity?
FEATURING
Aaron Yeoh
- 3,615 views
- June 13, 2023
- 21
Practical Ways to Achieve Targets in Diabetes Care
ATDC 2022: The Ominous Octet and More
FEATURING
Ralph DeFronzo
- 2,269 views
- July 27, 2022
- 20
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,355 views
- November 30, 2023
- 20
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,706 views
- November 21, 2023
- 19
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18